𝔖 Bobbio Scriptorium
✦   LIBER   ✦

150 - Subcutaneous (SC) interleukin-2 (IL-2) plus alpha interferon (IFN-α) and 5 fluorouracil (5 FU) in out-patients (pts) with metastatic renal cell carcinoma (MRCC). Scapp II trial

✍ Scribed by J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. Chretien; P. Salze; A. Monnier; Y. Brewer

Book ID
117664411
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
262 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of intravenous gemcitab
A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma
✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH